格隆汇3月3日丨华海药业(600521.SH)公布,截至2023年3月3日,公司股票在连续30个交易日中已有至少10个交易日的收盘价低于当期转股价格的80%,“华海转债”预计触发转股价格向下修正条件。若触发条件,公司将于触发条件当日召开董事会审议决定是否修正转股价格,并及时履行信息披露义务。
华海药业(600521.SH):“华海转债”预计触发转股价向下修正的条件
Huahai Pharmaceutical (600521.SH): “Huahai debt conversion” is expected to trigger a downward correction in the conversion price
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.